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Abstract
Background The p22phox gene encodes the main subunit of
NADH/NADPH-oxidase. This enzyme is expressed in
smooth muscle cells of arteries, and it produces the reactive
oxygen species. On the other hand, oxidative stress plays a
main role in the pathogenesis of coronary artery disease
(CAD).
Aim The aim of this study is to evaluate the association be-
tween rs4673 and rs1049255 polymorphisms of p22phox
gene with CAD in an Iranian population which was followed
with a computational analysis approach.
Methods In a cross-sectional study, we collected blood sam-
ples of 302 Iranian Caucasian including 143 patients and 159
healthy controls. Genotype of the polymorphisms was detect-
ed through PCR-RFLPmethod. A computational analysis was
also performed using SNAP, Polyphen-2, Chou-Fasman,
RNAsnp, and miRNA SNP databases.
Results Data of case control study demonstrated that CT ge-
notype (R = 1.84, 95% CI = 1.13–3.00, p = 0.014) and Tallele
(OR = 1.53, 95% CI = 1.09–2.15, p = 0.013) of rs4673 poly-
morphism, have a significant association with enhanced risk
of CAD. But rs1049255 analysis demonstrated the absence of
such an association with CAD. Indeed, in silico data analysis
demonstrated that rs4673 transition could impact on function
of p22phox protein (SNAP score 56, expected accuracy 75%;
Polyphen-2 score 0.99, sensitivity 0.09, specificity 0.99). Data
derived from miRNA SNP database demonstrated that
rs1049255 polymorphism increases the affinity of attachment
between has-miR-3689a-3b with 3′-UTR of p22phox gene.
Conclusion Our data demonstrated that rs4673 transition may
be involved in susceptibility to CAD and could be applied as a
potential biomarker for this disease.
Keywords Computationalanalysis .Coronaryarterydisease .
Genetic association . p22phox gene
Introduction
Coronary artery disease (CAD; OMIM: 608320), the most
common manifestation of cardiovascular diseases, is a multi-
factorial disease with complex etiology in which various en-
vironmental and genetic factors impact on its incidence [1].
Thus, evaluation of causes of CAD should encompass through
both risk factors as diabetes, hypertension, hyperlipidemia,
and genetic susceptibility [2, 3]. Oxidative stress plays a fun-
damental role in development of CAD as a primary pathogen-
ic step [4, 5]. Over production of reactive oxygen species
(ROS) due to imbalance in oxidative anti-oxidant systems,
results in subsequent inflammatory events in immune and en-
dothelial cells [6]. NADH/NADPH oxidases are the most im-
portant enzyme involved in innate immune system which pro-
duces active oxygen species. They most often express in vas-
cular smooth muscle cells (VSMCs), endothelial cell, and
phagocytosis [7]. The phagocytic NADH/NADPH oxidase
is a flavoprotein which includes two-transmembrane subunits
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(gp91phox and p22phox) and three cytosolic proteins
(p40phox, p47phox, and p67phox) [8]. Other NOX isoforms
are expressed in thyroid and colon cells and pair with p22phox
subunit [9]. Thus, p22phox is considered as an essential com-
ponent for NADH/NADPH oxidase function [10].
Nicotinamide adenine dinucleotide phosphate [NAD(P)H]
system might be involved in pathophysiology of CAD. This
system is the predominant source of ROS production in vas-
cular cells [11]. In addition, p22phox expression is more in
human atherosclerotic vs. non-atherosclerotic coronary arter-
ies [12].
The p22phox (CYBA) gene is located on long arm of chro-
mosome 16 (16q24) and encodes p22phox subunit [13], and it
has several polymorphisms [14]. Among them, rs4673 (c.214
T>C; also, it is traditionally known as C242T) and rs1049255
(c.*24G>A) polymorphisms have been widely investigated in
cardiovascular complications, but results are still controversial
[15]. The rs4673 polymorphism resulted in histidine to tyro-
sine substitution on codon 72 (Y72H) of protein, while
rs1049255 polymorphism is located on 3′-UTR of p22phox
gene (Fig. 1). This study aimed to evaluate the association
between aforementioned single nucleotide polymorphisms
(SNPs) and CAD in an Iranian population parallel with an in
silico analysis.
Methods and materials
Subjects
In this case-control study, total of 302 Iranian Caucasians in-
cluding 143 patients with CAD and 159 age-matched healthy
subjects were participants. Case group were selected from
CAD patients admitted to cardiology department of Shahid
Beheshti hospital (Kashan, Iran) with the age more than or
equal to 55 years old, between 2014 and 2015. CAD was
confirmed angiographically by stenosis severity 50% or more
in at least on coronary artery. Patients with history of diabetes
mellitus, malignancy, clinical evidence of coagulopathy,
collagenosis, acute intoxication (amphetamine and carbon ox-
ide), and cardiovascular, renal and hepatic disorders were ex-
cluded from this study. Control group included healthy sub-
jects referred to hospital for routine check-up tests with exclu-
sion criteria including signs and symptoms of acute myocar-
dial infarction, diabetes mellitus, CAD, and other familial and
genetic disorders. Some demographic data and biochemical
features of participants are included in Table 1. After getting
signed informed consent, 2 ml of blood was drawn from all
participants and collected in CBC tubes and stored at −20°C.
SNP genotyping
Genomic DNA was isolated from blood samples by a DNA
extraction kit (Bioneer Co., Korea). Polymerase chain
reaction-restriction fragment length polymorphism (PCR-
RFLP) method was used for genotyping of rs4673 and
rs1049255 polymorphisms. For this purpose, the fragments
containing aforementioned SNPs were amplified by specific
primers and condition which are given in Table 2. PCR was
performed by Eppendorf thermal cycler (Eppendorf Co.,
Germany) in 25 μl total volume containing 0.25 μM each of
forward and reverse primers, 1 mM MgCl2, 100 μM dNTP
mixture, 1 unit of Taq polymerase, and 50 ng of DNA tem-
plate. All of PCR reagents were purchased from Fermentas
Company (Fermentas, Leon-Rot, Germany). About 10 μl
(≈0.1 μg) of the PCR products containing c.214 T>C and
c.*24G>A polymorphisms were respectively treated with
5 units of RsaI (Fermentas) and DraIII (Fermentas) restriction
enzymes according to the protocol (Table 3). Genotypes of
rs4673 and rs1049255 polymorphisms were detected by 1%
agarose gel electrophoresis.
Fig. 1 The p22phox gene map
and PCR-RFLP results. Human
p22phox gene map was obtained
from NCBI which rs4673 and
rs1049255 are located on exons 4
and 6, respectively (a).
Restriction enzyme map of the
452-bp fragment following RsaI
treatment (b). Restriction enzyme
map of the 301-bp fragment
following DraIII treatment (c)
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Computational analysis
Complete coding sequence of p22phox gene was obtained
from NCBI database (Accession number: NC_000016). The
impact of rs4673 polymorphism on function and structure of
protein was evaluated using SNAP [16] and PolyPhen-2 [17]
software. Indeed, the impact of this transition on protein hy-
drophobicity was evaluated through Kyte-Doolittle scale [18].
The possible impacts of Y72H substitution on secondary
structure of protein was evaluated using Chou-Fasman meth-
od [19]. The impact of rs4673 and rs1049255 transitions on
mRNA structure was evaluated using RNAsnp web server
[20]. The miRNA SNP ver2.0 database was used for evalua-
tion of miRNA interaction with 3′-UTR of p22phox transcript
[21]. In order to predict the impact of rs1049255 on affinity
between 3′-UTR of p22phox gene with miRNAs, the above
mentioned server was applied.
Statistical analysis was performed using SPSS ver.19 soft-
ware (SPSS Inc., IBM Corp Armonk, NY, USA). The numer-
ical variables were compared by independent t-test whereas
qualitative variables were compared by chi-squared test.
Hardy–Weinberg equilibrium (HWE) was calculated for both
case and control groups through chi-squared test. The associ-
ation of various genotypes and alleles with CAD risk was
assessed by odds ratio (OR) and 95% confidence interval
(CI) which were calculated by binary logistic regression. A
p value less than 0.05 was considered statistically significant.
Results
PCR-RFLP
Human genome showed a principal bandwith lowmobility on
agarose gel after electrophoresis. While human genome was
applied as template in PCR, p22phox fragments including
rs4673 and rs1049255 were produced with 452- and 301-bp
length, respectively. After electrophoresis of digested products
of rs4673, CC, CT, and TT genotypes showed one (452-bp),
three (452-, 283-, and 169-bp), and two (169- and 83-bp)
bands on agarose gel, respectively. But regarding rs1049255
polymorphisms, GG, AG, and AA genotypes showed one
(301-bp), three (301-, 203-, and 98-bp) and two (203-
and98-bp) bands on agarose gel, respectively.
Allelic and genotypic frequency distribution
Statistical analysis demonstrated that frequency distribution of
rs4673 (χ2 = 0.642, p = 0.422) and rs1049255 (χ2 = 2.100,
p = 0.147) genotypes in control group, were in the Hardy–
Weinberg equilibrium. Allelic and genotypic frequency distri-
bution of mentioned polymorphism in a case and control
groups are shown in Tables 4 and 5. Regarding rs4673 poly-
morphism, frequency distribution of CC, CT, and TT geno-
types in case group were 35.66, 50.35, and 13.99%, respec-
tively. While these values for control groups were 50.94,
38.99, and 10.07%, respectively. Genotype analysis revealed
a significant association between CT genotype and CAD risk
(OR = 1.84, 95% CI = 1.13–3.00, p = 0.014). Indeed, T allele
carriers (CT + TT) showed increased risk for development of
CAD (OR = 1.87, 95% CI = 1.18–2.97, p = 0.008). Allelic
analysis demonstrated a significant association between T al-
lele and CAD risk (OR = 1.53, 95% CI = 1.09–2.15,
p = 0.013). Genotype evaluation of rs1049255 polymorphism
demonstrated that frequency of AA, AG, and GG genotypes
in case group, were 42.66, 39.86, and 17.48%, respectively.
While these ratios in control group, were 49.06, 38.36, and
12.58%, respectively. Statistical analysis revealed absence of
any association between AG (OR = 1.19, 95% CI = 0.73–
1.96, p = 0.479) and GG (OR = 1.60, 95% CI = 0.81–3.14,
p = 0.174) genotypes with CAD risk. Indeed, G allelic of
rs1049255 polymorphism was not associated with CAD risk
(OR = 1.28, 95% CI = 0.92–1.80, p = 0.145).
Table 1 Demographic and biochemical features of the subjects
Variables Case (n = 143) Control (n = 159) p value
Age (years) 62.32 ± 3.05 61.64 ± 3.96 0.099
Gender (m/f) 95/48 112/47 0.454
Smoking (y/n) 64/79 64/95 0.429
BMI (kg/m2) 24.608 ± 2.46 24.33 ± 2.34 0.320
HDL (mg/dl) 42.61 ± 4.55 42.11 ± 4.44 0.333
LDL (mg/dl) 116.21 ± 14.70 112.80 ± 19.23 0.082
TG (mg/dl) 134.35 ± 23.94 129.07 ± 25.65 0.066
TC (mg/dl) 136.80 ± 24.28 140.97 ± 23.19 0.129
The data are expressed as mean ± standard deviation
Mmale, F female, Y yes, N no, BMI body mass index, HDL high density
lipoprotein, LDL low-density lipoprotein, TG triglycerides, TC total
cholesterol
Table 2 Primer sequences and
polymerase chain reaction
conditions
SNP
(rs no.)
Primer sequence (5′→3′) PCR conditions Product
size
c.214 T>C
(rs4673)
5′-TGGAGCGCTGGTGAGTCTCC 30 cycles of 94 °C (30 s),
59 °C (45 s), and 72 °C (45 s)
452-bp
5′-GTGGCTCCTGTCCAGGCAGC
c.*24G>A
(rs1049255)
5′-CCGGGAGCGGCCGCAGATCG 30 cycles of 94 °C (30 s),
63 °C (45 s), and 72 °C (45 s)
301-bp
5′-AGGCCTCGGGAACCATCGCT
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In silico analysis
Bioinformatics analysis demonstrated a significant impact of
rs4673 polymorphism on structure and function of p22phox
protein. Data derived from SNAP server demonstrated that
histidine to tyrosine substitution at codon72 of p22phox pro-
tein might be considered as a functional mutation for protein
(with score: 56; expected accuracy: 75%; Fig. 2). Data from
Polyphen-2 software in both HumDiv (score, 1.00; sensitivity
0.00; specificity 1.00) and HumVar (score, 0.99; sensitivity
0.09; specificity 0.99) algorithm demonstrated significant im-
pact of rs4673 polymorphism on protein function (Fig. 2).
Hydrophobicity analysis demonstrated reduced rate of hydro-
phobicity at codon 72 from −0.311 to −0.522 consequent to
Y72H substitution (Fig. 3). Chou-Fasman analysis revealed
altered secondary structure of protein by rs4673 polymor-
phism (Fig. 3). This analysis demonstrated reduced percent-
age of sheet structures in mutated state from 57.9 to 55.4%.
Effects of rs4673 and rs1049255 polymorphisms on
mRNA structure were evaluated using RNAsnp server.
Absence of any impact on mRNA structure by rs4673 (dis-
tance 0.0122; p value 0.823) and rs1049255 (distance 0.0324;
p value 0.648) polymorphisms was observed (Fig. 4). In this
study, we have evaluated the effects of rs1049255
polymorphism which is located on 3′-UTR of gene, on inter-
action between miRNA and 3′-UTR of p22phox gene. Data
derived from miRNA SNP database v2.0 demonstrated that
rs1049255 polymorphism results in increased strength of af-
finity between has-miR-3689a-3b and 3′-UTR of p22phox
gene. The energy derived from attachment of wide type and
mutant mRNA with this miRNA was −24.5 and −25.0 kcal/
mol, respectively (Fig. 4).
Discussion
Nowadays, CAD is considered as a great clinical problem,
worldwide [22]. Despite of advances made in this filed, pre-
vention remained still the best challenging with this disease.
Thus, identification of CAD risk factors is paramount value.
Several genetic factors involved in enhanced susceptibility to
CAD [23, 24]. Polymorphism of genes involved in reactive
oxygen species system such as p22phox gene could be con-
sidered as important risk factors for CAD [25]. In this study,
the association between rs4673 and rs1049255 polymorphism
with CAD in an Iranian population was evaluated. In our
study, CT genotype and T allele of rs4673 polymorphism
showed significant association with CAD risk. But analysis
of rs1049255 polymorphism demonstrated that GG and AG
Table 3 Digestion conditions of
the restriction enzymes SNP
(rs no.)
Restriction
enzyme
Restriction site Digestion products (bp)
Wild type Mutant type Heterozygote
c.214 T>C
(rs4673)
RsaI GT^AC 452 283, 169 452, 283, 169
c.*24G>A
(rs1049255)
DraIII CACNNN^GTG 203, 98 301 301, 203, 98
Table 4 Genotype and allele frequencies of c.214 T>C in cases and
controls
Genotype/allele No. and percentage OR (95% CI) p value
Control
(n = 159)
Case
(n = 143)
CC 81
(50.94%)
51
(35.66%)
− −
CT 62
(38.99%)
72
(50.35%)
1.84 (1.13–3.00) 0.014
TT 16
(10.07%)
20
(13.99%)
1.99 (0.94–4.18) 0.071
CT + TT 78
(49.06%)
92
(64.34%)
1.87 (1.18–2.97) 0.008
C 224
(70.44%)
174
(60.83%)
− −
T 94
(29.56%)
112
(39.17%)
1.53 (1.09–2.15) 0.013
Significant differences between the case and control groups are italicized
OR odds ratio, CI confidence interval
Table 5 Genotype and allele frequencies of c.*24G>A in cases and
controls
Genotype/allele No. and percentage OR
(95% CI)
p value
Control
(n = 159)
Case
(n = 143)
AA 78
(49.06%)
61
(42.66%)
− −
AG 61
(38.36%)
57
(39.86%)
1.19 (0.73–1.96) 0.479
GG 20
(12.58%)
25
(17.48%)
1.60 (0.81–3.14) 0.174
AG + GG 81
(50.94%)
82
(57.34%)
1.29 (0.82–2.04) 0.266
A 217
(68.24%)
179
(62.59%)
− −
G 101
(31.76%)
107
(37.41%)
1.28 (0.92–1.80) 0.145
OR odds ratio, CI confidence interval
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genotypes and G allele, had no significant association with
CAD risk. By now, several investigations have been per-
formed regarding association between rs4673 and rs1049255
polymorphisms of p22phox gene and CAD risk. Recently,
results of these studies have been evaluated in two meta-
analysis [15, 25]. Wu et al. (2013) have evaluated the associ-
ation between rs4673 polymorphism of p22phox gene with
CAD risk in a meta-analysis approach. They revealed the as-
sociation between rs4673 polymorphism and CAD risk under
the recessive genetic model in Caucasian population [25]. But
Fig. 2 SNAP and Polyphen2 prediction results. SNAP predicted Y72H substitution as a functional mutation (a). Polyphen-2 predicted Y72H mutation
to be damaging according to homology search (b). The residue 72 is shown by arrowhead
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Fig. 4 Results of RNAsnp and miRNA SNP databases. Confined
area with determined differences in mutant and wild-type
p22phox-mRNA for rs4673 (A) and rs1049255 (A ′) . The
probabilities of wild-type and mutant sequences are presented in
upper and lower triangle of the plots, respectively. The
polymorphic position is highlighted in yellow (A and A′). The
rs1049255G>A transition increases the affinity of has-miR-3689a-
3b with 3′-UTR of p22phox (B)
Fig. 3 Hydrophobicity and
secondary structure predictions.
Hydrophobicity plot for 72Y and
72H phenotypes, respectively (A
and A′). ChoueFasman’s
secondary structure for 72Y and
72H phenotypes, respectively (B
and B′). The residue 72 is shown
by boxes
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Xu et al. (2014) showed protective effect of rs4673 polymor-
phism on CAD risk in Asian population. Decreased risk of
CAD was also seen with rs1049255 polymorphism [15].
These controversial results from similar studies could be at-
tributed to racial and environmental factors.
The relationship between p22phox gene and CAD risk
could be explained through some molecular mechanisms.
Some empirical findings are in favor of physiologic roles of
some of the p22phox gene polymorphisms, in which some of
them are able to modify expression and activity of NADPH
oxidase in the cardiovascular disease [26]. In an animal model
of essential hypertension, enhanced activity of aortic NADPH
oxidase and increased expression of p22phox in spontaneous-
ly hypertensive vs. normotensive rats were seenwhich suggest
that altered p22phox expression might be regulated through
genetic variants of p22phox [27]. Our previous genetic asso-
ciation studies demonstrated that in silico analysis is an appro-
priate approach for evaluation of polymorphism effect on
mRNA structure [28, 29], protein function [30, 31], and gene
expression [32]. The rs4673 polymorphism is a non-
synonymous single nucleotide polymorphisms (nsSNPs) with
histidine to tyrosine substitution on codon 72 of p22phox
protein with the ability to alter structure and function of
p22phox protein. Savas et al. 2006, have demonstrated that
this polymorphism is possibly damaging for protein structure
[33]. Najafi et al. (2012) have identified the absence of any
effect of this polymorphism on secondary structure of protein
[14]. Our bioinformatics analysis have demonstrated any im-
pact of rs4673 polymorphism on mRNA structure, but sec-
ondary structure and function of protein were both altered in
this setting. Indeed, we detected no effect by rs1049255 poly-
morphism on 3′-UTR of gene on mRNA structure of p22phox
gene. But this polymorphism alters the binding affinity of has-
miR-3689a-3b with 3′-UTR which might impact the expres-
sion of the gene. In an experimental study, Bedard et al. (2009)
created reporter constructs containing luciferase coding se-
quence and variants (c.*24G and c.*24A) of the p22phox 3′-
UTR. They observed that the construct with 3′-UTR contain-
ing c.*24G variant had an activity similar to the control con-
struct. But, the construct with 3′-UTR containing c.*24A var-
iant had a substantially decreased reporter gene activity [34].
With regard to rs4673 polymorphism, our in silico analysis
revealed that this polymorphism has a significant effect on the
p22phox protein function. By the same token, Zhu et al.
(2006) reported that this SNPmight influence protein function
because it located in an important region for maturation of the
protein [35].
One limitation of this study is the lack of angio-
graphic results of control subjects. Some other limita-
tions of our study include small sample size, and further
studies with larger sample size and different races and
considering gene-gene and gene-environmental interac-
tion are needed.
Conclusions
Our data demonstrated that rs4673 polymorphism may be
potential risk factor for CAD in Iranian populations.
Although this association was not seen with rs1049255 poly-
morphism, this polymorphism could alter the affinity for at-
tachment of miRNAwith 3′-UTR of gene.
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